Induction of t(11;14) IgH enhancer/promoter-
CRISPR/CRISPR-associated protein 9
cyclin D1
immunoglobulin H enhancer
multiple myeloma
t(11;14)(q13;q32)
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
07
09
2018
accepted:
18
04
2019
entrez:
11
7
2019
pubmed:
11
7
2019
medline:
11
7
2019
Statut:
ppublish
Résumé
Chromosomal translocation is a key process in the oncogenic transformation of somatic cells. Previously, artificial induction of chromosomal translocation was performed using homologous recombination-mediated loxP labeling of target regions followed by Cre-mediated recombination. Recent progress in genome editing techniques has facilitated the easier induction of artificial translocation by cutting two targeted genome sequences from different chromosomes. The present study established a system to induce t(11;14)(q13;q32), which is observed primarily in multiple myeloma (MM) and involves the repositioning of the
Identifiants
pubmed: 31289497
doi: 10.3892/ol.2019.10303
pii: OL-0-0-10303
pmc: PMC6539856
doi:
Types de publication
Journal Article
Langues
eng
Pagination
275-282Références
Blood. 2000 Apr 15;95(8):2691-8
pubmed: 10753852
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Blood. 2002 May 15;99(10):3735-41
pubmed: 11986230
Genomics. 1992 Jul;13(3):565-74
pubmed: 1386335
Genes Chromosomes Cancer. 2004 Feb;39(2):151-5
pubmed: 14695995
Curr Protoc Mol Biol. 2001 May;Chapter 9:Unit9.12
pubmed: 18265280
Cell. 2008 Apr 18;133(2):265-79
pubmed: 18423198
Biochim Biophys Acta. 2008 Dec;1786(2):139-52
pubmed: 18718509
Nucleic Acids Res. 2011 Aug;39(14):5813-25
pubmed: 21498543
Nat Rev Immunol. 2012 Jun 25;12(7):517-31
pubmed: 22728528
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
Science. 2013 Feb 15;339(6121):768-70
pubmed: 23413345
Blood. 2013 Apr 25;121(17):3413-9
pubmed: 23435460
Trends Biotechnol. 2013 Jul;31(7):397-405
pubmed: 23664777
Sci Rep. 2013 Nov 27;3:3355
pubmed: 24284873
Nat Commun. 2014 Apr 24;5:3728
pubmed: 24759083
Cell Stem Cell. 2015 Feb 5;16(2):142-7
pubmed: 25658371
Nat Methods. 2015 Oct;12(10):982-8
pubmed: 26322839
PLoS One. 2015 Sep 09;10(9):e0136644
pubmed: 26351841
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
Nat Commun. 2016 Jan 28;7:10548
pubmed: 26817820
Nat Rev Immunol. 2016 Mar;16(3):164-76
pubmed: 26898111
Sci Rep. 2016 Feb 22;6:21918
pubmed: 26898344
Nat Rev Cancer. 2016 May 25;16(6):387-98
pubmed: 27220482
BMC Genomics. 2016 Sep 17;17(1):739
pubmed: 27640184
J Pathol. 2017 May;242(1):102-112
pubmed: 28188619
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3696-3701
pubmed: 28325870
Sci Rep. 2017 May 10;7(1):1659
pubmed: 28490810
Haematologica. 2017 Sep;102(9):1558-1566
pubmed: 28572162
Sci Rep. 2017 Aug 21;7(1):8943
pubmed: 28827551
Nat Med. 2018 Jul;24(7):939-946
pubmed: 29892062
Nat Med. 2018 Jul;24(7):927-930
pubmed: 29892067
Nature. 1994 Nov 10;372(6502):143-9
pubmed: 7969446
Biochem Biophys Res Commun. 1994 Jul 29;202(2):830-7
pubmed: 8048955
Genomics. 1993 Jun;16(3):745-50
pubmed: 8325649
Cell. 1993 Jun 18;73(6):1059-65
pubmed: 8513492
Mol Cell Biol. 1996 Jun;16(6):2554-60
pubmed: 8649362
Blood. 1996 Jul 15;88(2):674-81
pubmed: 8695815
Nat Genet. 1997 Jul;16(3):260-4
pubmed: 9207791
Blood. 1998 Jun 15;91(12):4457-63
pubmed: 9616139
Blood. 1999 Feb 15;93(4):1330-7
pubmed: 9949176